|
2025
|
G/S
|
Pharmaceutical preparations and substances for the treatment
of cardiovascular diseases and diso... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disor... |
|
2024
|
Invention
|
Treatment of enpp1 deficiency and abcc6 deficiency.
The present disclosure provides, among other... |
|
|
Invention
|
Methods of improving cardiovascular function and treating cardiovascular disease using a recombin... |
|
|
Invention
|
Treatment of enpp1 deficiency and abcc6 deficiency in children. in vivoin vivo treatment of an EN... |
|
|
Invention
|
Lyophilized enpp1 polypeptide formulations and uses thereof.
In certain aspects, the present inv... |
|
2023
|
Invention
|
Liver specific production of enpp1 or enpp3.
The present disclosure provides, among other things... |
|
|
Invention
|
Treatment of enpp1 deficiency and abcc6 deficiency. The present disclosure provides, among other ... |
|
2022
|
Invention
|
Compositions and methods for treating allograft vasculopathy, moyamoya disease, moyamoya syndrome... |
|
|
Invention
|
Compositions and methods for treating peripheral artery disease.
The present disclosure provides... |
|
|
Invention
|
Compositions and methods for inhibiting vascular smooth muscle cell proliferation.
The present d... |
|
|
Invention
|
Lyophilized enpp1 polypeptide formulations and uses thereof. In certain aspects, the present inve... |
|
|
Invention
|
Treatment of diseases involving deficiency of enpp1 or enpp3.
The present disclosure provides, a... |
|
|
Invention
|
Npp1 fusion proteins.
The present invention provides a novel fusion polypeptide containing a cat... |
|
|
Invention
|
Methods of treating myointimal proliferation.
The present invention provides a method of treatin... |
|
2021
|
Invention
|
Liver specific production of enpp1 or enpp3. in vivoin vivo and methods for the treatment of dise... |
|
|
G/S
|
Pharmaceutical preparations for the diagnosis and therapeutic treatment of bone and kidney diseas... |
|
|
G/S
|
Pharmaceutical preparations for the diagnosis and
therapeutic treatment of diseases or disorders... |
|
|
Invention
|
Soluble enpp1 or enpp3 proteins and uses thereof. In certain aspects, the present invention provi... |
|
|
Invention
|
Compositions and methods for treating peripheral artery disease. The present disclosure provides ... |
|
|
Invention
|
Compositions and methods for inhibiting vascular smooth muscle cell proliferation. The present di... |
|
2020
|
G/S
|
therapeutic pharmaceutical for the diagnosis and treatment of diseases or disorders afflicting th... |
|
|
G/S
|
Pharmaceutical preparations; diagnostic preparations for medical purposes; none of the aforesaid ... |
|
|
Invention
|
Treatment of diseases involving deficiency of enpp1 or enpp3. in vivo in vivo and methods for the... |
|
2018
|
G/S
|
Pharmaceutical preparations, in particular therapeutic pharmaceuticals for the diagnosis and trea... |
|
|
G/S
|
Pharmaceutical preparations and substances for use in the diagnosis and treatment of bone disease... |
|
2017
|
Invention
|
Methods of treating tissue calcification. The present invention provides a method of treating NPP... |
|
|
Invention
|
Methods of treating myointimal proliferation. The present invention provides a method of treating... |
|
2014
|
Invention
|
Npp1 fusion proteins. The present invention provides a novel fusion polypeptide containing a cata... |
